Spectators Allowed at Churchill’s Fall Meet

Churchill Downs will open its 131st Fall Meet Sunday, Oct. 25, by allowing spectators for the first time since the COVID-19 pandemic began this past spring. It will mark the first time this year that fans can attend live racing at Churchill.

The Louisville track will continue to follow the COVID-19 health and safety protocols mandated by the Commonwealth of Kentucky. Temperature checks, medical questionnaires, physical distancing and mandatory face coverings will be required. Capacity will be limited as per Kentucky’s requirements for venues and event spaces. Last year’s average daily attendance during the Fall Meet was 4,200.

There will be no general admission, but reserved box seats will be sold for prices ranging from $5-$12. Dining options will also be available for a range of $39-$72. Children ages 12 and under are free, as is parking.

Tickets may be purchased online at churchilldowns.com/tickets/. For updated information on Churchill’s safety guidelines and procedures, visit churchilldowns.com/tickets/admissions-services/updates.

Sunday’s 11-race program, which will feature the 16th annual “Stars of Tomorrow I” card for 2-year-olds, will kick off at 1 p.m. ET. The meet runs for 24 days over five weeks through Nov. 29, except Nov 6-7, when the Breeders’ Cup will be held at Keeneland.

The post Spectators Allowed at Churchill’s Fall Meet appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Taking Stock: Fifth-Year Stallions and Brody’s Cause

Much has been made lately in Kentucky on farms reducing stud fees in response to the blighted economy, but there’s a group of stallions whose fees would have mostly dropped as a matter of course even in booming times. These are second- through fifth-year stallions; frequently, fees for horses entering their fifth season at stud as their first-crop runners turn three show particularly pronounced drops from their initial fees.

A small commercial breeder contacted me the other day to discuss the reduced 2021 stud fee for a stallion whose first crop is racing at two now. She noted how well the stallion matches her mare on pedigree and physique and the 50% reduction in fee from his first year at stud but worried that “his first 2-year-olds are not yet lighting the racetrack on fire, and his sales figures plummeted this year.”

This is a common dilemma for breeders and stud farms alike. Farms need to price fifth-year horses caught in this tricky bubble attractively enough to attract breeders in order to keep both groups in the game on stallions whose long-term viability in Kentucky will be determined in the next year or two. One false move in pricing could spell commercial disaster for one, the other, or both.

And it’s not just pricing, either, as I told this breeder. “You’d be breeding in his fifth year at stud. You’ll have 5-year-olds, 4-year-olds, 3-year-olds, and 2-year-olds [racing] when you sell [your yearling], so you’d have to really like him, because if they are not successful, it will be tough. And even if they are successful, there’s a ceiling [on price] unless he turns into Curlin.”

Curlin, who’d entered stud at Lane’s End in 2009 for a $75,000 fee, got his first winner in the most dreaded of places–the Central Moscow Hippodrome in Russia, on June 17, 2012. He finished the year ninth on the freshman sire list with no 2-year-old stakes winners to his credit and stood for $25,000 in 2013–his fifth year at stud. The stallion’s yearling average in 2012 was $70,000 versus $137,000 in 2011 for his first-crop yearlings. However, the Horse of the Year eventually turned things around, and by 2015, when his first crop was five, his yearlings averaged $211,000. Curlin will stand for $175,000 in 2021, the same as this year. His 2020 yearlings to date have averaged $342,000.

Stallions with first-crop 3-year-olds next year can change perceptions quickly with a few early-season stakes winners, particularly if they’re on the Classic trail, guaranteeing patronage for another year or two by finishing out the season strong with two crops–3-year-old and 2-year-olds–at the races.

Daredevil did some of this in 2020 with Gl Preakness S. and GI Alabama S. winner Swiss Skydiver and Gl Kentucky Oaks winner Shedaresthedevil after a poor run with his first 2-year-olds, but by then he’d already been jettisoned from Kentucky after only four seasons at stud.

However, it’s the rare stallion that can carry that momentum forward, because he’ll need to do it with mares of decreasing quality in years two, three, and four. Most stallions tend to have their highest output of stakes winners from their first crop, when they get their best mares, and numbers tend to decrease commensurately with a decrease in mare quality.

I noted in this space Feb. 27 (Third- And Fourth-Year Sire Issues) that of the top 10 freshman sires of 2017, five had left Kentucky by 2020–when their first foals were five–including the leader, Overanalyze, along with Shanghai Bobby (#3), Animal Kingdom (#4), Flat Out (#7), and Justin Phillip (#10).

Brody’s Cause

A strong opinion on a horse, formed by an analysis of facts and an evaluation of price versus the competition, is the best way to approach a fifth-year stallion.

For example, Spendthrift’s multiple Grade l winner Brody’s Cause (Giant’s Causeway), a $350,000 yearling purchase for Albaugh Family Stables trained by Dale Romans, will stand in 2021, his fifth year, for $5,000, down from the $12,500 he started out at in 2017 and the $7,500 he was listed at this year. He is ninth on the freshman sire list through today behind leader Not This Time (Giant’s Causeway), another Albaugh horse whose fee has jumped to $40,000 in 2021 from an initial $15,000 in 2017 and the $12,500 in 2020.

However, Brody’s Cause has eye-opening stats versus the competition and at the price.

Both Not This Time and Brody’s Cause are each represented by two black-type winners so far–the most among freshman sires, along with Nyquist (Uncle Mo), whose 2021 fee is $75,000; and Outwork (Uncle Mo), who stands next year for $15,000.

Brody’s Cause is also tied with Not This Time and Nyquist in the top 10 by number of black-type runners with four apiece, but he’s done this from 55 foals to 95 for Not This Time and 80 for Nyquist.

As for the quality of his runners, five of his six winners have won maiden special weights while another, the Bob Baffert-trained filly Kalypso, won for the first time in the Listed Anoakia S. Oct. 18 at Santa Anita after placing in two Del Mar maiden special weights. Kalypso, by the way, was a $240,000 Fasig-Tipton Kentucky July yearling.

On the same day of Kalypso’s win, the gelding Gospel Way ran second in the Listed Display S. at Woodbine–his second stakes placing after a third in the Victoria S. at the same track.

Earlier this month, Brody’s Cause showcased another talented maiden winner. A $185,000 Fasig-Tipton Saratoga yearling for Albaugh and Romans, Smiley Sobotka graduated at Keeneland in his second start in the style of a horse who looks to have a bigger future next year at three. The colt had dead-heated for second in his debut at Ellis over 6 1/2 furlongs but found the mile and a sixteenth at Keeneland much more to his liking.

This brings me to Sittin On Go, Brody’s Cause’s most accomplished runner to date. A $65,000 Keeneland November weanling and $62,000 Keeneland September RNA, he also races for Albaugh and is trained by Romans. Sittin On Go won his debut at Ellis in a five-furlong dirt sprint by four-plus lengths in mid-August and returned last month in the one-mile Glll Iroquois S. at Churchill to win impressively by 2 1/2 lengths. The runner up, Midnight Bourbon (Tiznow), ran third in his next start in the GI Champagne S. at Belmont, though he was beaten by more than 14 lengths by the leader of the division, Jackie’s Warrior (Maclean’s Music). However, the third-place finisher in the Iroquois, Super Stock (Dialed In), also came back to place third to Essential Quality (Tapit) in the Gl Breeders’ Futurity at Keeneland, less than five lengths behind the winner.

Sittin On Go has solid Grade l formlines, and he will test Jackie’s Warrior in the Breeders’ Cup Juvenile next.

Brody’s Cause has one other stakes horse, Girther. A $2,500 Keeneland November weanling, $4,000 Keeneland September yearling, and $20,000 OBS March 2-year-old, Girther won a Del Mar maiden special weight in July in his second start and came back a month later at the same venue to run a neck second to Weston (Hit It a Bomb, also at Spendthrift) in the Gll Best Pal S.

Brody’s Cause won three of eight starts, including the Breeders’ Futurity at two and the GI Toyota Blue Grass S. at three, both at Keeneland, and earned $1,168,138. His sire Giant’s Causeway doesn’t yet have an elite son in North America, but he did in Europe with Shamardal, who died earlier this year. Here, he has the good First Samurai at Claiborne plus several others trying to rise to that level, but in Not This Time and Brody’s Cause he’s still got his name in the hat with two promising young guns, and who knows?

Spendthrift’s flagship horse Into Mischief also started off for $12,500, dropped to $7,500, and is now booked full at $225,000. And the farm’s elder statesman, Malibu Moon, began his career at Country Life in Maryland for $3,000 and went on to sire a GI Kentucky Derby winner among many others of note.

My advice to the small breeder looking for value at $15,000 and down? For the price, Brody’s Cause is worth the gamble.

Sid Fernando is president and CEO of Werk Thoroughbred Consultants, Inc., originator of the Werk Nick Rating and eNicks.

The post Taking Stock: Fifth-Year Stallions and Brody’s Cause appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Thoroughbred Safety Coalition Adopts New Reforms

The Thoroughbred Safety Coalition has added eight medical and operational reforms to its platform. The group’s Steering Committee, made up of executives from the Breeders’ Cup, Churchill Downs Incorporated, Del Mar Thoroughbred Club, Keeneland Association Inc., the New York Racing Association (NYRA) and The Stronach Group, voted unanimously to adopt the reforms with the ultimate goal of uniform implementation across racing jurisdictions.

The following reforms have been added to the Coalition’s platform:

  • Strengthen race entry and eligibility requirements;
  • Work with state racing commissions to apply racing regulations surrounding prohibited substances and restrict selected therapeutic substances in proximity to high-speed works;
  • Prohibit the administration of external treatments, therapies and musculoskeletal manipulation within at least 24 hours of a race;
  • Work with state racing commissions to implement a clenbuterol prohibition in racing and training along with reporting/procedural requirements as outlined by the RMTC;
  • Strengthen requirements for removing horses from the Veterinarians’ List;
  • Adopt a waiver claiming option for horses coming off an extended layoff;
  • Require implementation of an emergency track warning system; and
  • Modify racetrack on and off gaps to increase horse and rider safety.

“As today’s announcement and recent progress make clear, the Coalition’s important work to ensure the well-being of our athletes has continued despite the challenging circumstances our industry and our nation have faced this year. The new reforms will go a long way toward increasing our collective ability to identify at-risk horses before they set foot on a track and protect the integrity of our sport,” said Coalition Strategic Advisor Donna Brothers.

The post Thoroughbred Safety Coalition Adopts New Reforms appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Study Finds Three Biomarkers That Could Help Predict Fatal Racing Injuries

As the quest continues for a better way to identify racehorses at risk for fatal injury, a study from the University of Kentucky's Gluck Equine Research Center may provide scientists and veterinarians a roadmap of where to look. At a regularly scheduled meeting Oct. 22, the Kentucky Horse Racing Commission received initial results from a study by Gluck researchers Dr. Allen Page and David Horohov looking at inflammatory biomarkers. Biomarkers are proteins, which can be produced at different levels in the body depending on changes and normal processes like inflammation.

Researchers have looked at biomarkers before to try finding some that would signal inflammation that may still be subclinical, or not producing recognizable symptoms yet in the horse. Previous efforts have yielded mixed results, in part because the body undergoes some amount of normal inflammation in response to exercise even when the horse isn't battling an underlying injury. Other biomarkers don't show up until the injury occurs, which makes them useless from a predictive standpoint.

Thanks to funding provided by the Kentucky Equine Drug Research Council (KEDRC), Page and Horohov are in the midst of a two-phase research project — the first looking at a new set of biomarkers and the second looking at messenger RNA, which signals the production of proteins like biomarkers. The second phase is still in progress, and Tuesday's meeting focused on the results from the first phase.

Page and Horohov gathered data from racetracks in four racing jurisdictions, testing blood taken pre-race for TCO2 testing and comparing results between horses who suffered fatal musculoskeletal injuries and competitors from the same races who did not. They examined 21 markers and found three — IGF-1, MMP-2, and IL1RN — which were present in different levels in injured horses versus non-injured horses.

These results made sense to the researchers. IGF-1 is known to play a role in bone development and repair, and it was increased in injured horses, suggesting chronic inflammation was present. Matrix metalloproteinase-2, or MMP-2, is thought to assist with tissue repair and fracture remodeling and was also elevated in injured horses. Interestingly, IL1RN is more commonly known as IRAP–a anti-inflammatory material derived from a horse's own blood and given therapeutically by veterinarians to reduce inflammation and aid in healing an injured horse. IRAP was decreased in fatally injured horses, suggesting the body's natural anti-inflammatory process had been disrupted for some reason. Horses with higher levels of IRAP were actually seven times less likely to suffer fatal injuries.

While those results are encouraging, Page cautioned that it will still be challenging to practically apply the new information. The three biomarkers weren't perfect predictors of impending injury; 24 percent of the time, a horse would not appear to be at risk based on its biomarker levels when in fact it did suffer a fatal injury and 12 percent of the time, tests suggested the horse was at risk of a fatal injury but the horse finished the race without a catastrophic breakdown.

Overall, the three biomarkers provided about 88 percent accuracy at identifying horses at risk.

The test is also expensive and in a research setting the tests took around 48 hours to complete. Page pointed out that those estimates are based on his team's study, where samples had to be tested for 21 different biomarkers. Reducing the number of markers tested would shorten that time, but it would still likely take 24 hours to get results.

Then there's the question of what to do with horses whose blood indicates they may be at risk. It remains unclear whether the commission legally can or should mandate imaging, particularly if the horse doesn't appear lame and no one is sure where the problem might be. Then there's the question of false positive tests — if a horse's entry was contingent upon a biomarker test, horses could be pulled from races who weren't actually at elevated risk, and it would be hard to know which were which.

Commission members acknowledged it will be a challenge to determine how biomarker data could be practically applied to a time sensitive screening process.

Page said he's hopeful the second phase of the study, which looks “upstream” at mRNA responsible for the production of proteins like biomarkers, may provide more specific guidance.

See Page's presentation here:

The post Study Finds Three Biomarkers That Could Help Predict Fatal Racing Injuries appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights